Accession Therapeutics is a startup based in the United States, most recent round Series-c-plus, 1 tracked investor.
Accession Therapeutics is a company founded in 2018 headquartered in the United States. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
Accession Therapeutics is a biotechnology company focusing on the development of new therapeutic options for cancer treatment.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.